Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03654746 in Adults with Tourette's Syndrome
NCT01475383Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-03654746 in Tourette syndrome (TS), sponsored by Pfizer. Planned start Apr 2012; status: withdrawn.
02
Drugs
PF-03654746
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01475383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475383.